Mika K. Derynck

Insider Reports History

Entity
Individual
Location
C/O Amunix Pharmaceuticals, Inc., 2 Tower Place, #1100, South San Francisco, CA
Signature
/s/ Ben Hohl, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mika K. Derynck:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Enliven Therapeutics, Inc. Director Stock Option (right to buy) 23.4K Feb 13, 2024 Direct

Insider Reports Filed by Mika K. Derynck

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4/A Feb 20, 2024 Director
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 1 $0 4 Apr 6, 2023 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 0 $0 3 Feb 27, 2023 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 1 $0 4 Feb 27, 2023 Director